Spatial and lineage trajectory mapping revealed that POSTN+ mesenchymal fibroblasts—enriched in keloids—had increased TGF‐β signaling and ECM output, whereas IGFBP2+ fibroblasts in healthy skin presented antifibrotic phenotypes and resistance to TGF‐β–induced activation [114]. This evidence concerns the gene TGFB1 and keloid.